Impacts of Government Reimbursement Negotiation on Targeted Anticancer Medication Price, Volume and Spending in China

2020 ◽  
Author(s):  
Yichen Zhang ◽  
Haishaerjiang Wushouer ◽  
Sheng Han ◽  
Mengyuan Fu ◽  
Xiaodong Guan ◽  
...  
Keyword(s):  
Government Reimbursement

PP482 Invasive Electroencephalography In The Pre-Surgical Diagnosis Of Pharmacoresistant Epilepsy

2020 ◽  
Vol 36 (S1) ◽  
pp. 38-38
Author(s):  
Andrey Avdeyev ◽  
Azat Shpekov ◽  
Valeriy Benberin ◽  
Nasrulla Shanazarov ◽  
Leilya Ismailova ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Meta Analysis ◽  
Epileptogenic Zone ◽  
Pharmacoresistant Epilepsy ◽  
Simple Method ◽  
Integrated Method ◽  
Accurate Localization ◽  
Functional Zones ◽  
Severity Of The Disease ◽  
Government Reimbursement

IntroductionWorldwide, more than 50 million people suffer from epilepsy, and there are 16–51 new cases per 100,000 population each year. Up to 30 percent of patients with epilepsy are pharmacoresistant, who are candidates for surgical treatment. Invasive electroencephalography (iEEG) is a mandatory method in the arsenal of epileptic centers, and is gradually becoming the gold standard for invasive determination of boundaries between the affected and functional zones of the cortex and subcortical brain. Treatment costs correlate with the severity of the disease, with patients having uncontrolled seizures incurring eight times the costs compared to those with controlled epilepsy.MethodsTo assess the clinical and cost-effectiveness of the iEEG in the pre-surgical diagnosis of pharmacoresistant epilepsy, a systematic search of literature by keywords in the MEDLINE database was conducted. The search resulted in sixty-six articles. The analysis included twenty studies that met the search criteria.ResultsMost studies including meta-analysis show very low rates of complications of iEEG. Literature data demonstrate cost-effectiveness of the method in patients with pharmacoresistant epilepsy in comparison with continued antiepileptic drug therapy. As an integrated method, rather than a simple method, it takes maximum account of clinical, neurophysiological and anatomical-functional data to achieve accurate localization of the epileptogenic zone. Currently, iEEG is a clinically effective method to improve the safety and specificity of resective surgery.ConclusionsWith the use of iEEG, mortality and disability of patients with pharmacoresistant epilepsy will be significantly reduced. It has also been proven that epilepsy surgery leads to significant financial savings in the treatment of pharmacoresistant epilepsy. The results of the clinical and economic evaluation (mini-HTA report) have been submitted to the Ministry of Healthcare for decision-making on including iEEG in government reimbursement system.

Cost Models with Prominent Outliers

2010 ◽  
pp. 368-398
Author(s):  
Chakib Battioui
Keyword(s):  
Average Cost ◽  
Cost Models ◽  
Fixed Amount ◽  
Local Conditions ◽  
The People ◽  
The Cost ◽  
Government Reimbursement

Government reimbursement programs, such as Medicare and Medicaid, generally pay hospitals less than the cost of caring for the people enrolled in these programs. For many patient conditions, Medicare and Medicaid pay hospitals a fixed amount based upon average cost for a procedure or treatment with local conditions taken into consideration. In addition, while the hospital provides the services, it has little control over the cost of delivery of that service, which is determined more by physician orders. The physician is under no real obligation to control those costs as the physician bills separately for services that are independent of orders charged. However, some patients who are severely ill will cost considerably more than average. This has caused providers to lose money. In this study, we investigate the reimbursement policies and the assumptions that have been made to create these reimbursement policies.

scholarly journals Successful control program to implement the appropriate antibiotic prophylaxis for cesarean section

2008 ◽  
Vol 50 (2) ◽  
pp. 79-82 ◽  
Author(s):  
Silvia Nunes Szente Fonseca ◽  
Maria Helena Sofia ◽  
Silvana Quintana ◽  
Fernanda Dos Santos Nogueira ◽  
Anna S. Levin
Keyword(s):  
Cesarean Section ◽  
Intervention Program ◽  
Antimicrobial Prophylaxis ◽  
Surgical Site Infections ◽  
Control Program ◽  
Post Discharge ◽  
Post Intervention ◽  
Successful Control ◽  
A Prospective Study ◽  
Government Reimbursement

OBJECTIVE: Describe implementation of a successful program to reduce doses (cefazolin 2 to 1 g) used for antimicrobial prophylaxis. METHODS: Evaluation of an intervention program to reduce prophylactic antimicrobial doses. The intervention included weekly staff discussions, automatic dispensation of 1g-vial of cefazolin by the pharmacy unless expressly requested by surgeon and increase in post-discharge surveillance as a strategy to reassure surgeons of the safety of the reduction. In the pre and post intervention periods, a prospective study of antimicrobial consumption and surgical site infections were measured. RESULTS: There were 5,164 and 5,204 deliveries in 2001-2002 and 2003-2004, respectively; 1,524 (29.5%) and 1,363 (26%) were cesarean sections. There was a 45% decrease in cefazolin vials used on average per cesarean section (2.29 to 1.25). Patients evaluated increased from 16% to 67% and the SSI rates in both periods were 3.34% to 2.42%, respectively. CONCLUSION: An ample intervention, including administrative and educational measures, led to high compliance with dose reduction and saved more than US$4,000 in cefazolin, considered important because government reimbursement in Brazil for cesarean section is $80.

Automated Peritoneal Dialysis in Asia

1999 ◽  
Vol 19 (2_suppl) ◽  
pp. 125-129 ◽  
Author(s):  
Kar Neng Lai ◽  
Sing Leung Lui ◽  
Daniel T.M. Chan
Keyword(s):  
Peritoneal Dialysis ◽  
Capita Income ◽  
Utilization Rate ◽  
Automated Peritoneal Dialysis ◽  
Per Capita Income ◽  
Treatment Rate ◽  
Dialysis Adequacy ◽  
Per Capita ◽  
Asian Pacific ◽  
Government Reimbursement

The socioeconomic statuses of Asian countries are diverse, and government reimbursement policies for renal replacement programs vary greatly from one country to another. Both factors affect not only the availability of treatment, but also the choice of dialysis modality. A close correlation is demonstrated between the dialysis treatment rate for end-stage renal disease (ESRO) and the gross domestic product (GOP) per capita income. A biphasic relationship with the GOP per capita income and the peritoneal dialysis (PO) utilization rate is observed, in that the countries with the highest and lowest treatment rates tend to have lower PO utilization rates, whereas countries with modest treatment rates tend to have higher PO utilization rates. In contrast, countries with high continuous ambulatory peritoneal dialysis (CAPO) utilization rates have the lowest automated peritoneal dialysis (APO) utilization rates. The low APO utilization rates are due to fact that, in most instances, patients themselves must purchase the APO machine, and the machines are relatively more expensive in Asian Pacific countries. Continuous cycling peritoneal dialysis (CCPO) is most frequently practiced. Generally, convenience for employment is the main indication for the utilization of APO. Other important indications are the convenience of treatment in young or elderly uremic patients. Contrary to the practice in CAPO treatment, detailed documentation of dialysis adequacy and nutritional status is not routinely done in patients undergoing APO treatment in most Asian Pacific countries. In conclusion, APO is an underdeveloped treatment modality in the renal replacement programs of Asian Pacific countries. The low utilization of APO is clearly influenced by non medical factors including government reimbursement policy and the cost of PO machines.

scholarly journals Medicines and the media: news reports of medicines recommended for government reimbursement in Australia

2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Jane Robertson ◽  
Emily J Walkom ◽  
Marc D Bevan ◽  
David A Newby
Keyword(s):  
News Reports ◽  
The Media ◽  
Government Reimbursement

scholarly journals The Impact of Ultra-widefield Retinal Imaging on Practice Efficiency

2017 ◽  
Vol 10 (01) ◽  
pp. 27 ◽  
Author(s):  
Paul E Tornambe ◽  
Keyword(s):  
Quality Care ◽  
Retinal Imaging ◽  
Cost Effective ◽  
The United States ◽  
Care Plans ◽  
Healthcare Environment ◽  
Practice Efficiency ◽  
Government Reimbursement ◽  
The Impact

I n the current cost- and resource-constrained healthcare environment in the United States, characterized by declining government reimbursement and increased utilization scrutiny by managed care plans, providers are challenged to continue delivering quality care to more patients while also more effectively managing practice economics. Employing technology to improve practice efficiency is one of the most promising solutions to this dilemma. We have demonstrated that the integration of ultra-widefield (UWF) retinal imaging in our practice is cost-effective. It has allowed us to increase the number of patient encounters while simultaneously raising the quality of care, and increasing patient satisfaction.

scholarly journals Success of Big Infectious Disease Reimbursement Policy in China

2020 ◽  
Vol 57 ◽  
pp. 004695802090778
Author(s):  
Kun-xi Nie ◽  
Chan Wang ◽  
Xin-wu Li
Keyword(s):  
Infectious Disease ◽  
Infectious Diseases ◽  
Large Scale ◽  
Government Intervention ◽  
Treatment Costs ◽  
Evolution Model ◽  
Reimbursement Policy ◽  
Major Purpose ◽  
The Government ◽  
Government Reimbursement

Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government’s intervention in large-scale infectious diseases is successful and efficient. Two potential strategies were considered: strategy 1 was infectious disease without government intervention, and strategy 2 was infectious disease with government intervention. By evolution model, this article illustrates the efficiency of big infectious disease reimbursement policy in China. Without government reimbursement, this article finds that high expenditures accelerate the disease infection. The number of infected persons decreases under big infectious disease reimbursement policy in China. The higher the treatment costs, the more important the government intervention. Big infectious disease reimbursement policy in China can serve as an efficient example to cope with big infectious diseases.

Sign in / Sign up

Export Citation Format

Share Document